Dextroamphetamine
- Generic Name
- Dextroamphetamine
- Brand Names
- Adderall, Dexedrine, Mydayis, Procentra, Xelstrym, Zenzedi
- Drug Type
- Small Molecule
- Chemical Formula
- C9H13N
- CAS Number
- 51-64-9
- Unique Ingredient Identifier
- TZ47U051FI
Overview
Dextroamphetamine is the dextrorotary enantiomer of amphetamine. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.
Background
Dextroamphetamine is the dextrorotary enantiomer of amphetamine. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.
Indication
Dextroamphetamine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Narcolepsy
Clinical Trials
FDA Approved Products
Dextroamphetamine Sulfate
Manufacturer:Strides Pharma Science Limited
Route:ORAL
Strength:5 mg in 1 1
Approved: 2022/03/25
NDC:64380-230
MYDAYIS
Manufacturer:Takeda Pharmaceuticals America, Inc.
Route:ORAL
Strength:9.375 mg in 1 1
Approved: 2023/10/25
NDC:54092-474
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Manufacturer:Burel Pharmaceuticals, LLC
Route:ORAL
Strength:1.25 mg in 1 1
Approved: 2023/12/07
NDC:35573-464
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2019/07/22
NDC:63629-1973
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Manufacturer:Elite Laboratories, Inc.
Route:ORAL
Strength:7.5 mg in 1 1
Approved: 2023/12/11
NDC:64850-515
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath